SAB Biotherapeutics Inc (NASDAQ: SABS) announced the presentation of safety and pharmacologic data from a GLP toxicology study for SAB-142, a fully human immunotherapeutic being developed for delaying the onset and progression of Type 1 Diabetes.
As Bitcoin (CRYPTO: BTC) oscillates between $25,000 and $27,000, a popular cryptocurrency analyst and long-term trader Michaël van de Poppe told Benzinga that the key to surviving the bear market is to maintain a long-term perspective.
Chris Camillo, the host of the DumbMoney.tv, joined Benzinga founder Jason Raznick on "The Raz Report" Friday to discuss how Camillo predicts social changes to drive his investment decisions.
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information.
For some, this may be overwhelming.